Vol. 31 (2) 2024 – 07

Association of serum IL-30 and soluble GP130 with the risk of psoriasis vulgaris The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 61 – 70. www.Ejimmunology.org https://doi.org/10.55133/eji.310207 Rofaida R. Shehata1, Sara A. Atta2, Abd-Elsamea S....

Vol. 31 (2) 2024 – 06

Clinical significance of viral markers testing by ELISA and Individual Donation Nucleic Acid Testing (ID-NAT) for blood screening in blood bank: Single center study in Egypt The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 55 – 60....

Vol. 31 (2) 2024 – 05

Vitamin D receptor gene polymorphism in Egyptian multiple sclerosis patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 44 – 54. www.Ejimmunology.org https://doi.org/10.55133/eji.310205 Nermin R. Abdelwahab1, Randa R. Mabrouk1, Nahla M....

Vol. 31 (2) 2024 – 04

Plasma metadherin mRNA expression in bladder cancer The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 28 – 43. www.Ejimmunology.org https://doi.org/10.55133/eji.310204 Zeinab A. Abd Elhameed1, Lubna M. Tag El Din1, Tahra Sherif1, Amal M. Abdel Aal1,...

Vol. 31 (2) 2024 – 03

Assessment of Stx-1A gene polymorphism (rs1569061) in relation to the development of multiple sclerosis in Egyptian patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 18 – 27. www.Ejimmunology.org https://doi.org/10.55133/eji.310203...

Vol. 31 (2) 2024 – 02

 Identification of some variable parameters in serum of COVID-19 patients in comparison with control group The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 10 – 17. www.Ejimmunology.org https://doi.org/10.55133/eji.310202 Ebtihal C. Abbas1, Mais M....